RTA 402 (bardoxolone methyl)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RTA 402 (bardoxolone methyl), covering 2025-05-29 to 2025-05-29. Get the full timeline:
Most recent: Clinical Trial Update: Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer [Phase 1]